Market Closed -
Nasdaq
04:00:02 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
16.22
USD
|
+5.39%
|
|
+1.19%
|
-37.88%
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
46,232
|
32,946
|
43,898
|
30,301
|
21,849
|
13,993
|
-
|
-
|
Enterprise Value (EV)
1 |
62,045
|
48,668
|
51,685
|
39,503
|
30,172
|
21,166
|
20,770
|
19,937
|
P/E ratio
|
11.9
x
|
73.1
x
|
17.3
x
|
7
x
|
-7.09
x
|
-1.94
x
|
8.24
x
|
6.95
x
|
Yield
|
3.47%
|
4.92%
|
3.7%
|
5.45%
|
-
|
8.72%
|
6.4%
|
7.81%
|
Capitalization / Revenue
|
0.34
x
|
0.24
x
|
0.33
x
|
0.23
x
|
0.16
x
|
0.1
x
|
0.09
x
|
0.09
x
|
EV / Revenue
|
0.45
x
|
0.35
x
|
0.39
x
|
0.3
x
|
0.22
x
|
0.15
x
|
0.14
x
|
0.13
x
|
EV / EBITDA
|
7.37
x
|
6.82
x
|
7.87
x
|
6.3
x
|
6.03
x
|
4.31
x
|
3.95
x
|
3.27
x
|
EV / FCF
|
15.9
x
|
11.8
x
|
12.4
x
|
18.2
x
|
214
x
|
15.2
x
|
9.41
x
|
7.54
x
|
FCF Yield
|
6.27%
|
8.45%
|
8.08%
|
5.48%
|
0.47%
|
6.56%
|
10.6%
|
13.3%
|
Price to Book
|
1.95
x
|
1.59
x
|
1.84
x
|
1.03
x
|
0.77
x
|
0.95
x
|
0.9
x
|
0.81
x
|
Nbr of stocks (in thousands)
|
903,143
|
866,534
|
864,987
|
864,257
|
863,261
|
862,713
|
-
|
-
|
Reference price
2 |
51.19
|
38.02
|
50.75
|
35.06
|
25.31
|
16.22
|
16.22
|
16.22
|
Announcement Date
|
10/28/19
|
10/15/20
|
10/14/21
|
10/13/22
|
10/12/23
|
-
|
-
|
-
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
136,866
|
139,537
|
132,509
|
132,703
|
139,081
|
145,306
|
150,788
|
157,141
|
EBITDA
1 |
8,413
|
7,138
|
6,567
|
6,268
|
5,002
|
4,906
|
5,259
|
6,100
|
EBIT
1 |
6,942
|
5,211
|
5,117
|
5,133
|
3,871
|
3,051
|
3,512
|
3,947
|
Operating Margin
|
5.07%
|
3.73%
|
3.86%
|
3.87%
|
2.78%
|
2.1%
|
2.33%
|
2.51%
|
Earnings before Tax (EBT)
1 |
4,527
|
743
|
1,995
|
3,985
|
-5,419
|
-12,945
|
1,529
|
1,333
|
Net income
1 |
3,982
|
456
|
2,542
|
4,337
|
-3,080
|
-7,176
|
1,806
|
2,163
|
Net margin
|
2.91%
|
0.33%
|
1.92%
|
3.27%
|
-2.21%
|
-4.94%
|
1.2%
|
1.38%
|
EPS
2 |
4.310
|
0.5200
|
2.930
|
5.010
|
-3.570
|
-8.371
|
1.969
|
2.335
|
Free Cash Flow
1 |
3,892
|
4,111
|
4,176
|
2,165
|
141
|
1,389
|
2,207
|
2,643
|
FCF margin
|
2.84%
|
2.95%
|
3.15%
|
1.63%
|
0.1%
|
0.96%
|
1.46%
|
1.68%
|
FCF Conversion (EBITDA)
|
46.26%
|
57.59%
|
63.59%
|
34.54%
|
2.82%
|
28.31%
|
41.97%
|
43.32%
|
FCF Conversion (Net income)
|
97.74%
|
901.54%
|
164.28%
|
49.92%
|
-
|
-
|
122.22%
|
122.21%
|
Dividend per Share
2 |
1.778
|
1.870
|
1.880
|
1.912
|
-
|
1.414
|
1.038
|
1.267
|
Announcement Date
|
10/28/19
|
10/15/20
|
10/14/21
|
10/13/22
|
10/12/23
|
-
|
-
|
-
|
Fiscal Period: August |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
---|
Net sales
1 |
33,901
|
33,756
|
32,597
|
32,449
|
33,382
|
34,862
|
35,415
|
35,422
|
36,707
|
37,052
|
35,967
|
36,066
|
37,764
|
37,899
|
37,589
|
EBITDA
1 |
2,277
|
1,931
|
1,232
|
993
|
1,510
|
1,774
|
1,556
|
1,013
|
1,028
|
1,244
|
1,147
|
1,131
|
1,362
|
1,474
|
1,346
|
EBIT
1 |
1,777
|
1,657
|
955
|
744
|
1,014
|
1,215
|
959
|
683
|
687
|
900
|
740.6
|
726.2
|
836.8
|
1,037
|
943.3
|
Operating Margin
|
5.24%
|
4.91%
|
2.93%
|
2.29%
|
3.04%
|
3.49%
|
2.71%
|
1.93%
|
1.87%
|
2.43%
|
2.06%
|
2.01%
|
2.22%
|
2.74%
|
2.51%
|
Earnings before Tax (EBT)
1 |
3,814
|
947
|
-18
|
-758
|
-5,270
|
607
|
-382
|
-375
|
-358
|
-13,114
|
321.5
|
264.8
|
438.2
|
579.2
|
542.7
|
Net income
1 |
3,580
|
883
|
289
|
-415
|
-3,721
|
703
|
118
|
-180
|
-67
|
-5,908
|
233.3
|
236.2
|
361.3
|
507.9
|
457
|
Net margin
|
10.56%
|
2.62%
|
0.89%
|
-1.28%
|
-11.15%
|
2.02%
|
0.33%
|
-0.51%
|
-0.18%
|
-15.95%
|
0.65%
|
0.66%
|
0.96%
|
1.34%
|
1.22%
|
EPS
2 |
4.130
|
1.020
|
0.3300
|
-0.4800
|
-4.310
|
0.8100
|
0.1400
|
-0.2100
|
-0.0800
|
-6.850
|
0.2333
|
0.2455
|
0.3820
|
0.5579
|
0.4961
|
Dividend per Share
2 |
0.4775
|
0.4775
|
0.4775
|
0.4800
|
0.4800
|
-
|
0.4800
|
-
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
0.3638
|
0.2500
|
Announcement Date
|
1/6/22
|
3/31/22
|
6/30/22
|
10/13/22
|
1/5/23
|
3/28/23
|
6/27/23
|
10/12/23
|
1/4/24
|
3/28/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
15,813
|
15,722
|
7,787
|
9,202
|
8,323
|
7,173
|
6,777
|
5,943
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.88
x
|
2.203
x
|
1.186
x
|
1.468
x
|
1.664
x
|
1.462
x
|
1.289
x
|
0.9743
x
|
Free Cash Flow
1 |
3,892
|
4,111
|
4,176
|
2,165
|
141
|
1,389
|
2,207
|
2,643
|
ROE (net income / shareholders' equity)
|
22.3%
|
18.9%
|
20.5%
|
16.4%
|
11.9%
|
13.7%
|
17.9%
|
18.6%
|
ROA (Net income/ Total Assets)
|
5.87%
|
0.59%
|
5.46%
|
5.06%
|
3.68%
|
-9.79%
|
2.02%
|
2.6%
|
Assets
1 |
67,861
|
77,380
|
46,566
|
85,705
|
-83,627
|
73,278
|
89,445
|
83,174
|
Book Value Per Share
2 |
26.30
|
23.80
|
27.50
|
34.00
|
32.80
|
17.10
|
17.90
|
20.10
|
Cash Flow per Share
2 |
6.060
|
6.230
|
6.410
|
4.500
|
2.620
|
4.320
|
4.460
|
4.490
|
Capex
1 |
1,702
|
1,374
|
1,379
|
1,734
|
2,117
|
1,543
|
1,610
|
1,681
|
Capex / Sales
|
1.24%
|
0.98%
|
1.04%
|
1.31%
|
1.52%
|
1.06%
|
1.07%
|
1.07%
|
Announcement Date
|
10/28/19
|
10/15/20
|
10/14/21
|
10/13/22
|
10/12/23
|
-
|
-
|
-
|
Last Close Price
16.22
USD Average target price
22.58
USD Spread / Average Target +39.23% Consensus |
1st Jan change
|
Capi.
|
---|
| -37.88% | 13.99B | | -33.12% | 10.67B | | -22.64% | 6.75B | | +12.54% | 6.29B | | -11.17% | 5.88B | | +75.00% | 4.93B | | -4.38% | 4.54B | | -9.20% | 3.74B | | -19.40% | 3.16B | | -12.15% | 2.85B |
Other Drug Retailers
|